註冊用户突破4億,平安好醫生(1833.HK)上半年營收38.18億
8月24日,平安健康醫療科技有限公司(股票簡稱:平安好醫生,1833.HK)發佈2021年中期業績報吿。2021上半年,平安健康實現總收入38.18億元,同比增長39.0%。其中,醫療服務同比增長50.6%,收入達10.67億元;消費醫療同比增長66.1%,收入達7.14億元。
受益於用户對互聯網診療服務的認知提升,公司核心運營指標亦表現優異:截至2021年6月30日,註冊用户數達到4億人,較2020年同期增加近5500萬人;近12個月累計付費用户數高達3210萬人,同比增長69.6%。
平安健康通過聚焦皮膚科、中醫科、婦產科三大專科,圍繞健康管理、亞健康管理、疾病管理、慢病管理四大場景,為用户提供“一人一醫”,協調安排貫穿線上到線下的醫療健康相關服務,打造“省時、省力、省心、省錢”的用户體驗。
隨着核心醫療能力的不斷提升,平安健康將進一步聚焦於金融渠道和企業客户渠道的高價值用户轉化,一方面通過醫療健康會員類產品、健康管理服務等,賦能平安集團“有温度的金融”,另一方面為企業員工定製健康管理方案,成為企業僱主心中的健康夥伴和員工身邊的健康守護。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.